Vivanza Biosciences Limited (BOM:530057)
India
· Delayed Price · Currency is INR 2.020
+0.090 (4.66%)
At close: Mar 10, 2026
Vivanza Biosciences Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | - | 1.17 | 1.67 | 1.41 | 0.55 | -30.93 | Upgrade
|
| Short-Term Investments | - | 0.3 | 0.29 | 0.29 | 0.01 | - | Upgrade
|
| Cash & Short-Term Investments | 6.01 | 1.47 | 1.96 | 1.7 | 0.56 | -30.93 | Upgrade
|
| Cash Growth | 251.17% | -25.03% | 15.11% | 203.21% | - | - | Upgrade
|
| Accounts Receivable | - | 80.59 | 115.39 | 124.79 | 78.4 | 62.51 | Upgrade
|
| Receivables | - | 97.03 | 131.62 | 166.11 | 97.69 | 73.05 | Upgrade
|
| Inventory | - | 22.63 | 20.06 | 24.75 | 24.28 | 6.54 | Upgrade
|
| Other Current Assets | - | 2.72 | 3.77 | 2.98 | 1.98 | 1.48 | Upgrade
|
| Total Current Assets | - | 123.84 | 157.41 | 195.54 | 124.51 | 50.15 | Upgrade
|
| Property, Plant & Equipment | - | 6.99 | 7.05 | 6.8 | 6.82 | 6.9 | Upgrade
|
| Long-Term Investments | - | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
| Goodwill | - | 16.05 | 16.05 | 16.05 | 16.05 | 16.05 | Upgrade
|
| Other Intangible Assets | - | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 0.01 | 0.02 | 0.01 | 0.01 | 0 | Upgrade
|
| Other Long-Term Assets | - | 5.93 | 5.93 | 5.93 | 5.93 | 11.05 | Upgrade
|
| Total Assets | - | 164.53 | 195.01 | 224.77 | 155.62 | 84.48 | Upgrade
|
| Accounts Payable | - | 26.18 | 82.35 | 95.49 | 54.85 | 38.65 | Upgrade
|
| Accrued Expenses | - | 0.37 | 0.22 | 0.25 | 0.22 | 0.34 | Upgrade
|
| Short-Term Debt | - | 18.74 | 22.07 | 32.77 | 27.36 | 3.58 | Upgrade
|
| Current Portion of Long-Term Debt | - | 34.44 | 2.81 | 32.87 | 1.75 | - | Upgrade
|
| Current Income Taxes Payable | - | 0.23 | 2.67 | 1.43 | 0.25 | 0.49 | Upgrade
|
| Current Unearned Revenue | - | 5.42 | 4.19 | 6.6 | 3.98 | 4.31 | Upgrade
|
| Other Current Liabilities | - | 6.17 | 7.52 | 0.13 | 6.32 | 5.53 | Upgrade
|
| Total Current Liabilities | - | 91.54 | 121.81 | 169.53 | 94.73 | 52.88 | Upgrade
|
| Long-Term Debt | - | 33.35 | 26.82 | 14.33 | 25.97 | - | Upgrade
|
| Other Long-Term Liabilities | - | 0 | 0 | - | - | - | Upgrade
|
| Total Liabilities | - | 124.89 | 148.63 | 183.86 | 120.69 | 52.88 | Upgrade
|
| Common Stock | - | 40 | 40 | 40 | 40 | 40 | Upgrade
|
| Retained Earnings | - | -0.36 | 6.38 | 0.91 | -5.08 | -8.4 | Upgrade
|
| Shareholders' Equity | 46.14 | 39.64 | 46.38 | 40.91 | 34.93 | 31.6 | Upgrade
|
| Total Liabilities & Equity | - | 164.53 | 195.01 | 224.77 | 155.62 | 84.48 | Upgrade
|
| Total Debt | 101.32 | 86.52 | 51.7 | 79.97 | 55.08 | 3.58 | Upgrade
|
| Net Cash (Debt) | -95.31 | -85.05 | -49.74 | -78.27 | -54.52 | -34.5 | Upgrade
|
| Net Cash Per Share | -2.39 | -2.13 | -1.27 | -1.96 | -1.36 | -0.86 | Upgrade
|
| Filing Date Shares Outstanding | 39.08 | 40 | 40 | 40 | 40 | 40 | Upgrade
|
| Total Common Shares Outstanding | 39.08 | 40 | 40 | 40 | 40 | 40 | Upgrade
|
| Working Capital | - | 32.3 | 35.6 | 26.01 | 29.78 | -2.73 | Upgrade
|
| Book Value Per Share | 1.15 | 0.99 | 1.16 | 1.02 | 0.87 | 0.79 | Upgrade
|
| Tangible Book Value | 29.79 | 23.29 | 30.03 | 24.56 | 18.57 | 15.24 | Upgrade
|
| Tangible Book Value Per Share | 0.74 | 0.58 | 0.75 | 0.61 | 0.46 | 0.38 | Upgrade
|
| Land | - | 1.42 | 1.42 | 1.42 | 1.42 | 1.42 | Upgrade
|
| Buildings | - | 2.46 | 2.46 | 2.46 | 2.46 | 2.46 | Upgrade
|
| Machinery | - | 5.37 | 5.29 | 4.92 | 4.92 | 4.92 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.